A Victorian orthopaedic implants tender worth about $50 million has been abandoned after a medical device company gained access to confidential pricing submitted by its seven rivals.
HealthShare Victoria discovered in August that the breach had occurred in February, after a supplier raised the alarm. The agency said human error had allowed one bidder to open spreadsheets containing competitors’ prices.
The company, described in government correspondence as the “disclosee”, accessed the confidential file on multiple occasions during the tender process. Probity consultants concluded it may have gained a competitive advantage.
The tender involved supplies of hip, knee, shoulder, elbow and wrist implants for Victoria’s public hospitals. The eight bidders were DePuy, Stryker, Zimmer, Smith & Nephew, Corin, Medacta, Enovis and Amplitude.
HealthShare has required statutory declarations from two people who accessed the pricing file, confirming that all copies were deleted and had not been shared outside the organisation.
However, the agency told bidders it could not impose contractual or legal penalties on the recipient company because the breach was its own fault. The company was also allowed to continue competing for the contract.
HealthShare said bidders would not be compensated for the costs of preparing their submissions and would have to absorb the expense of the failed process.
A HealthShare spokeswoman said: “We acknowledge the concern [the error] has caused.” She declined to say how much the abandoned tender had cost the government or the competing companies.
Confidentiality central to public procurement
The breach has angered suppliers in an industry where pricing is closely guarded and public health contracts can be worth tens of millions of dollars. HealthShare manages supply chains for Victorian health services and hospitals, overseeing about $1.4 billion in annual spending.
Medical negligence lawyer Rosemary Listing said the loss of confidentiality could weaken the state’s bargaining position for years. “Competitive tendering is the main way governments protect public money when buying from large companies,” she said. “That protection depends entirely on confidentiality.”
She said a bidder that could see rival prices would have less incentive to submit its lowest offer, potentially reducing the money available for patient care. The competitive pressure, she warned, could not simply be restored by running the tender again.
The failure comes after a Victorian Auditor-General’s report in June 2025 raised questions about HealthShare’s procurement performance. It found the agency could not demonstrate that collective agreements were delivering measurable savings, while almost a quarter of its procurement contracts resulted in cost increases.
Health Minister Ingrid Stitt confirmed the orthopaedic implants tender had been cancelled and would be rerun. Her spokeswoman said: “The breach of commercial confidentiality in this tender is unacceptable.”
Opposition health spokeswoman Georgie Crozier said the abandoned process showed a “fresh start” was needed at November’s Victorian election, describing it as further evidence that the state government “cannot get the basics right”.
For hospitals and patients, the tender will determine which prostheses are available on hospital catalogues and which implants surgeons can offer. Orthopaedic surgeon John Cunningham said any replacement process should assess devices against revision rates recorded by the National Joint Replacement Registry before price was considered.
“We have world-leading data on which implants fail and when, and setting it aside to save a few dollars a case means the patient wears the second operation,” he said.
There is no immediate risk to supply because the existing prostheses contract remains in place until July 2027.
